TRISALUS LIFE SCIENCES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.57 USD | -4.30% |
|
-2.62% | -34.08% |
| 03/06 | TriSalus Life Sciences, Inc. Highlights Clinical Data from Phase 1b Perio-02 Trial | CI |
| 30/05 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
6f.oVj8oHnxnDnaT02_-FnftteqGm3jR8siKEstqDsxm9c.jDbLxjyp93qgdnvdtQa1wI71SR2yE4hqZHJbx31p0OLxEY_sCYfxb4M_Ig~c24c4243ea3f4a9f6a8e8409a3e2b08c
